Chinook Therapeutics

$16.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-1.00%) As of 4:28 PM UTC today

Why Robinhood?

You can buy or sell KDNY and other stocks, options, and ETFs commission-free!

About KDNY

Chinook Therapeutics, Inc. Common Stock, also called Chinook Therapeutics, is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. The listed name for KDNY is Chinook Therapeutics, Inc. Common Stock.

CEO

Eric L. Dobmeier

Employees

Headquarters

Seattle, Washington

Founded

2000

Market Cap

704.59M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

121.57K

High Today

$17.26

Low Today

$16.54

Open Price

$17.01

Volume

104.42K

52 Week High

$21.68

52 Week Low

$9.35

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

KDNY Earnings

-$0.29

-$0.19

-$0.10

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected May 3, Pre-Market